Detection of Complement C3 and Factor B Gene Expression in Normal Colorectal Mucosa, Adenomas and Carcinomas

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1998 Apr 7

PMID 9528886

Citations 30

Authors

A Andoh

Y Fujiyama

H Sakumoto

H Uchihara

T Kimura

S Koyama

T Bamba

Affiliations

Soon will be listed here.

Abstract

Local secretion of complement components in the human intestine has been previously reported. However, the cellular source has not been identified. In this study, we demonstrate complement C3 and factor B mRNA expression in the normal colonic mucosa by in situ hybridization analysis. C3 and factor B genes were found to be expressed at high levels in the epithelial cells of the lower parts of the crypts in colonic mucosa, and this expression decreased gradually from the crypt base to the luminal surface. At the upper crypt and the luminal surface, these genes almost disappeared. C3 and factor B genes were expressed in all crypts at the same level. Furthermore, C3 and factor B gene expression was also identified in adenomas and carcinomas. In these neoplastic tissues, C3 and factor B genes were expressed uniformly, and the polarized distribution observed in the normal crypts was not detected. It is likely that complement components are locally synthesized in the intestine, and that these complement components may actively participate in normal immune and inflammatory responses over the enormous surface area of the intestinal mucosa.

Citing Articles

Complement factor I knockdown inhibits colon cancer development by affecting Wnt/β-catenin/c-Myc signaling pathway and glycolysis.

Du Y, Jiang Y, Hou Y, Shi Y World J Gastrointest Oncol. 2024; 16(6):2646-2662.

PMID: 38994157 PMC: 11236223. DOI: 10.4251/wjgo.v16.i6.2646.

Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways.

Zhao Z, Li S, Liu L World J Gastroenterol. 2024; 30(21):2793-2816.

PMID: 38899332 PMC: 11185293. DOI: 10.3748/wjg.v30.i21.2793.

Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma.

He C, Li Y, Zhang R, Chen J, Feng X, Duan Y Oncol Lett. 2021; 21(6):478.

PMID: 33968194 PMC: 8100962. DOI: 10.3892/ol.2021.12739.

Evaluating the effect of spaceflight on the host-pathogen interaction between human intestinal epithelial cells and Salmonella Typhimurium.

Barrila J, Sarker S, Hansmeier N, Yang S, Buss K, Briones N NPJ Microgravity. 2021; 7(1):9.

PMID: 33750813 PMC: 7943786. DOI: 10.1038/s41526-021-00136-w.

Construction and prognostic analysis of miRNA-mRNA regulatory network in liver metastasis from colorectal cancer.

Cai R, Lu Q, Wang D World J Surg Oncol. 2021; 19(1):7.

PMID: 33397428 PMC: 7784011. DOI: 10.1186/s12957-020-02107-z.

References

Bogers W, Stad R, van Es L, Daha M . Immunoglobulin A: interaction with complement, phagocytic cells and endothelial cells. Complement Inflamm. 1991; 8(5-6):347-58. DOI: 10.1159/000463206. View

Halstensen T, Hvatum M, Scott H, Fausa O, Brandtzaeg P . Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease. Gastroenterology. 1992; 102(3):751-9. DOI: 10.1016/0016-5085(92)90155-r. View

Andoh A, Fujiyama Y, Bamba T, Hosoda S . Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol. 1993; 151(8):4239-47. View

Horiuchi T, Kim S, Matsumoto M, Watanabe I, Fujita S, Volanakis J . Human complement factor B: cDNA cloning, nucleotide sequencing, phenotypic conversion by site-directed mutagenesis and expression. Mol Immunol. 1993; 30(17):1587-92. DOI: 10.1016/0161-5890(93)90450-p. View

Zhang W, LACHMANN P . Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes. Immunology. 1994; 81(1):137-41. PMC: 1422296. View

Andoh A, Fujiyama Y, Bamba T, Hosoda S, Brown W . Complement component C3 production and its cytokine regulation by gastrointestinal epithelial cells. Adv Exp Med Biol. 1995; 371A:211-5. DOI: 10.1007/978-1-4615-1941-6_43. View

Niehans G, Cherwitz D, STALEY N, Knapp D, Dalmasso A . Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am J Pathol. 1996; 149(1):129-42. PMC: 1865231. View

Andoh A, Fujiyama Y, Sumiyoshi K, Sakumoto H, Bamba T . Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells. Gastroenterology. 1996; 111(4):911-8. DOI: 10.1016/s0016-5085(96)70058-6. View

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

10.

de Bruijn M, Fey G . Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci U S A. 1985; 82(3):708-12. PMC: 397115. DOI: 10.1073/pnas.82.3.708. View

11.

Feucht H, Jung C, Gokel M, Riethmuller G, Zwirner J, Brase A . Detection of both isotypes of complement C4, C4A and C4B, in normal human glomeruli. Kidney Int. 1986; 30(6):932-6. DOI: 10.1038/ki.1986.275. View

12.

Sollid L, Kvale D, Brandtzaeg P, Markussen G, Thorsby E . Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol. 1987; 138(12):4303-6. View

13.

Mestecky J, McGhee J . Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol. 1987; 40:153-245. DOI: 10.1016/s0065-2776(08)60240-0. View

14.

Ahnen D, Kinoshita K, Nakane P, Brown W . Differential expression carcinoembryonic antigen and secretory component during colonic epithelial cell differentiation and in colonic carcinomas. Gastroenterology. 1987; 93(6):1330-8. DOI: 10.1016/0016-5085(87)90263-0. View

15.

Kvale D, Lovhaug D, Sollid L, Brandtzaeg P . Tumor necrosis factor-alpha up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol. 1988; 140(9):3086-9. View

16.

Kvale D, Brandtzaeg P, Lovhaug D . Up-regulation of the expression of secretory component and HLA molecules in a human colonic cell line by tumour necrosis factor-alpha and gamma interferon. Scand J Immunol. 1988; 28(3):351-7. DOI: 10.1111/j.1365-3083.1988.tb01460.x. View

17.

Halstensen T, Mollnes T, Brandtzaeg P . Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence. Gastroenterology. 1989; 97(1):10-9. DOI: 10.1016/0016-5085(89)91409-1. View

18.

Halstensen T, Mollnes T, Garred P, Fausa O, Brandtzaeg P . Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology. 1990; 98(5 Pt 1):1264-71. DOI: 10.1016/0016-5085(90)90343-y. View

19.

Ahrenstedt O, Knutson L, Nilsson B, Nilsson-Ekdahl K, Odlind B, Hallgren R . Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med. 1990; 322(19):1345-9. DOI: 10.1056/NEJM199005103221903. View

20.

Schneiderman R, Lint T, Knight K . Activation of the alternative pathway of complement by twelve different rabbit-mouse chimeric transfectoma IgA isotypes. J Immunol. 1990; 145(1):233-7. View